A 26-week, placebo- and pioglitazone-controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus
H. S. Chou, K. E. Truitt, J. B. Moberly, D. Merante, Y. Choi, Y. Mun, A. PfütznerVolume:
14
Année:
2012
Langue:
english
Pages:
1
DOI:
10.1111/j.1463-1326.2012.01631.x
Fichier:
PDF, 703 KB
english, 2012